1. Home
  2. CBLL

as of 12-12-2025 3:43pm EST

$20.91
+$0.50
+2.45%
Stocks Nasdaq

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Chart Type:
Time Range:
Founded: 2014 Country:
United States
United States
Employees: N/A City: SUNNYVALE
Market Cap: 428.8M IPO Year: 2024
Target Price: $24.20 AVG Volume (30 days): 582.1K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.50 EPS Growth: N/A
52 Week Low/High: $10.01 - $32.75 Next Earning Date: 11-04-2025
Revenue: $82,813,000 Revenue Growth: 37.93%
Revenue Growth (this year): 37.43% Revenue Growth (next year): 27.87%

AI-Powered CBLL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.00%
75.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest CeriBell Inc. News

CBLL Breaking Stock News: Dive into CBLL Ticker-Specific Updates for Smart Investing

All CBLL News

Share on Social Networks: